About the paper
This article describes different design concepts for isolators used in the aseptic production of cells for CAR-T cell therapy. It outlines key features such as hydrogen peroxide decontamination, integrated equipment, and transfer systems, and compares isolator-based production with traditional cleanroom setups using biosafety cabinets.
Why the topic matters
CAR-T cell therapy requires highly controlled aseptic conditions to ensure product safety and efficacy. Choosing the right production environment is critical, as contamination risks directly impact patient outcomes. Isolator technology offers a potentially safer and more cost-effective alternative to traditional cleanroom approaches.